03:43 AM EST, 11/25/2025 (MT Newswires) -- Todd Watanabe, Director, President and Chief Executive Officer, on November 21, 2025, sold 50,000 shares in Arcutis Biotherapeutics ( ARQT ) for $1,517,405. Following the Form 4 filing with the SEC, Watanabe has control over a total of 973,671 common shares of the company, with 740,537 shares held directly and 233,134 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1787306/000180106125000012/xslF345X05/wk-form4_1764027931.xml